The authors compare brain tumor organoids (BTO) with common models including cell lines, tumor spheroids, and patient-derived xenografts. They conclude BTOs could be a reliable model to understand brain tumors and develop targeted therapies.
[CNS Neuroscience & Therapeutics]
